Rare disease patients in India are rarely involved in international orphan drug trials.
We wished to determine whether rare diseases patients from India had been enrolled in international trials to develop novel orphan drugs. There are two reasons to be interested in this. (a) Different ethnic or racial groups may respond differently to a particular drug. India has huge ethnic diversit...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Public Library of Science (PLoS),
2022-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|